![Ling Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ling Yang
Vorsitzender bei
ADICON HOLDINGS LIMITED
Vermögen: 297 782 $ am 30.09.2026
Profil
Ling Yang is currently Non-Executive Chairman at ADICON Holdings Ltd. since 2018, Non-Executive Director at HUTCHMED (China) Ltd. since 2023, Non-Executive Director at Ambio Pharmaceuticals Inc since 2021, Director at Ambio, Inc., Managing Director at Carlyle Asia Investment Advisors Ltd. since 2011, and Member of The Phi Beta Kappa Society.
Former roles include Director at Shenzhen Salubris Pharmaceuticals Co., Ltd., Director at Ambio Holdings, Inc., Vice President & Managing Director at The Carlyle Group Inc., Principal at KKR Asia Ltd. from 2008 to 2011, Associate at The Carlyle Group Inc. from 2005 to 2006, and Principal at Kohlberg Kravis Roberts & Co.(Beijing) from 2008 to 2011.
Education includes an undergraduate degree from Smith College in 2002 and an MBA from Harvard Business School in 2008.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.05.2026 | 502’500 ( 0.07% ) | 297 782 $ | 30.09.2026 |
Aktive Positionen von Ling Yang
| Unternehmen | Position | Beginn |
|---|---|---|
| ADICON HOLDINGS LIMITED | Vorsitzender | 12.10.2018 |
| HUTCHMED (CHINA) LIMITED | Direktor/Vorstandsmitglied | 13.07.2023 |
Carlyle Asia Investment Advisors Ltd.
 Carlyle Asia Investment Advisors Ltd. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.07.2011 |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Direktor/Vorstandsmitglied | 08.10.2020 |
Ambio, Inc.
 Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as drug development company | Direktor/Vorstandsmitglied | - |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ling Yang
| Unternehmen | Position | Ende |
|---|---|---|
KKR Asia Ltd.
 KKR Asia Ltd. Investment ManagersFinance Part of KKR & Co., Inc., KKR Asia Ltd. is a Chinese company. 'The company is based in Hong Kong, Hong Kong. The company was founded in 2001. Zheng Sun has been the CEO of the company since 2007. | Corporate Officer/Principal | 01.02.2011 |
Kohlberg Kravis Roberts & Co.(Beijing)
 Kohlberg Kravis Roberts & Co.(Beijing) Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.01.2011 |
| THE CARLYLE GROUP INC. | Corporate Officer/Principal | 01.08.2006 |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Ling Yang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
HUTCHMED (China) Ltd.
 HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Commercial Services |
KKR Asia Ltd.
KKR Asia Ltd. Investment ManagersFinance Part of KKR & Co., Inc., KKR Asia Ltd. is a Chinese company. 'The company is based in Hong Kong, Hong Kong. The company was founded in 2001. Zheng Sun has been the CEO of the company since 2007. | Finance |
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 Shenzhen Salubris Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research & development, production and sale of pharmaceuticals and medical devices | Health Technology |
Ambio Holdings, Inc.
 Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization focused on peptide active pharmaceutical ingredients | Health Technology |
Carlyle Asia Investment Advisors Ltd.
Carlyle Asia Investment Advisors Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
The Carlyle Group Inc.
 The Carlyle Group Inc. Investment ManagersFinance Provides alternative asset management and private equity services | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kohlberg Kravis Roberts & Co.(Beijing)
Kohlberg Kravis Roberts & Co.(Beijing) Investment ManagersFinance Functions as an alternative investment manager | Finance |
ADICON Holdings Ltd.
 ADICON Holdings Ltd. Medical/Nursing ServicesHealth Services Operates as a holding company whose subsidiaries provides medical testing services and trading of related equipment | Health Services |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Ambio, Inc.
Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as drug development company | Commercial Services |
